Growing insights into the potential benefits and risks of activated protein C administration in sepsis: a review of preclinical and clinical studies
Laith Altaweel, Daniel Sweeney, Xizhong Cui, Amisha Barochia, Charles Natanson, Peter Q EichackerCritical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, MD, USAAbstract: Recombinant human activated protein C (rhAPC) was developed to reduce excessive coagulant and...
Guardado en:
Autores principales: | Laith Altaweel, Daniel Sweeney, Xizhong Cui, et al |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2009
|
Materias: | |
Acceso en línea: | https://doaj.org/article/25811bbb6b944277b5ba7fd51db1aa93 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Optogenetics in preclinical neuroscience and psychiatry research: recent insights and potential applications
por: McDevitt RA, et al.
Publicado: (2014) -
Anti-risk Potential of Administrative Socialization
por: Sergei Boresobich Murashov
Publicado: (2018) -
Benefit of COVID-19 vaccination accounting for potential risk compensation
por: John P. A. Ioannidis
Publicado: (2021) -
The hypocretin/orexin system in sleep disorders: preclinical insights and clinical progress
por: Chow M, et al.
Publicado: (2016) -
Interaction Insights: A new category for a growing journal
por: Wayne Dawson
Publicado: (2020)